Transcription of AC (DOXOrubicin/Cyclophosphamide) Every 21 Days Course
{{id}} {{{paragraph}}}
BRS5a chemotherapy Order Template .. Breast Cancer AC (DOXO rubicin/ cyclophosphamide ) Every 21 days PACLI taxel Every 21 days AC (DOXO rubicin/ cyclophosphamide ) Every 21. days Course page 1 of 2. INDICATION: REFERENCES: NCCN SUPPORTIVE CARE: Adjuvant 1. NCCN Clinical Practice Guidelines in 1. Emetic Risk: Day 1 High Oncology Breast Cancer. 2. Fever Neutropenia Risk: Intermediate 2. Mamounas EP, et al. J Clin Oncol. 2005;23(16) chemotherapy REGIMEN. 21-day cycle for 4 cycles DOXO rubicin 60 mg/m2 IV Push on Day 1. cyclophosphamide 600 mg/m2 IV over 30 minutes on Day 1. Oral hydration is strongly encouraged with cyclophosphamide ; poorly hydrated patients may need supplemental IV hydration.
CHEMOTHERAPY REGIMEN. 21-day cycle for 4 cycles • DOXOrubicin 60 mg/m2 IV Push on Day 1 • Cyclophosphamide 600 mg/m2 IV over 30 minutes on Day 1 • Oral hydration is strongly encouraged with cyclophosphamide; poorly hydrated patients may need supplemental IV hydration.
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}